Showcases Stock ranks Forex

Innoviva Inc (INVA)
14.79  0.35 (2.42%) 08-08 16:00
Open: 14.46 Pre. Close: 14.44
High: 14.82 Low: 14.45
Volume: 476,299 Market Cap: 1,031M
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 14.821 - 14.873 14.873 - 14.92
Low: 14.301 - 14.368 14.368 - 14.429
Close: 14.684 - 14.777 14.777 - 14.863
Stock Technical Analysis
Target: Six months: 17.79
One year: 20.78
Support: Support1: 14.25
Support2: 13.64
Resistance: Resistance1: 15.23
Resistance2: 17.79
Pivot: 14.47
Moving Averages: MA(5): 14.38
MA(20): 14.45
MA(100): 16.12
MA(250): 16.63
MACD: MACD(12,26): -0.10
Signal(12,26,9): -0.14
%K %D: %K(14,3): 72.78
%D(3): 59.54
RSI: RSI(14): 54.32
52-Week: High: 20.71
Low: 13.64
Change(%): -9.5
Average Vol(K): 3-Month: 875
10-Days: 665
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

[ INVA ] has closed below upper band by 12.0%. Bollinger Bands are 53.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Mon, 08 Aug 2022
Los Angeles Capital Management LLC Acquires 53325 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World

Wed, 27 Jul 2022
Innoviva: Q2 Earnings Snapshot - CT Insider

Wed, 27 Jul 2022
Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress - Business Wire

Sun, 24 Jul 2022
DekaBank Deutsche Girozentrale Buys Shares of 33859 Innoviva, Inc. (NASDAQ:INVA) - Defense World

Wed, 20 Jul 2022
Goldman Sachs starts Innoviva with neutral rating, says royalty portfolio fairly valued - Seeking Alpha

Sat, 16 Jul 2022
Innoviva, Inc. (NASDAQ:INVA) Stock Position Raised by Zurcher Kantonalbank Zurich Cantonalbank - Defense World

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  NASDAQ Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 69.71
Shares Float (M) 57.37
% Held by Insiders 0.84
% Held by Institutions 114.53
Shares Short (K) 11070
Shares Short Prior Month (K) 11070
Stock Financials
EPS 1.400
Book Value (p.s.) 5.570
Profit Margin 24.64
Operating Margin 89.81
Return on Assets (ttm) 23.5
Return on Equity (ttm) 43.3
Qtrly Rev. Growth 7.4
Gross Profit (p.s.) 5.613
Sales Per Share 5.793
EBITDA (p.s.) 5.205
Qtrly Earnings Growth -98.50
Operating Cash Flow (M) 372.23
Levered Free Cash Flow (M) 251.61
Stock Valuation
PE Ratio 10.56
PEG Ratio
Price to Book value 2.66
Price to Sales 2.55
Price to Cash Flow 2.77
Stock Dividends
Dividend 0.250
Dividend Yield 0.02
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android